Erika Nicole Dreikorn

Dr. Erika Nicole Dreikorn

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2025 in Journal of the American Pharmacists Association
Verified
Journal Article
Open access
EDErika Nicole Dreikorn
Erika Nicole Dreikorn
SSSeth Sacchi
Seth Sacchi
KRKatherine Riden
Katherine Riden
PEPhilip Empey
Philip Empey
MMMylynda Beryl Massart
Mylynda Beryl Massart
LBLucas A. Berenbrok
Lucas A. Berenbrok
Integrating pharmacogenomic (PGx) test results into electronic health records (EHRs) represents a crucial step in the advancement of precision medicine. However, successful implementation is often hindered by lack of, or gaps in, clinician training; lack of clinician confidence; and system-level barriers such as limited awareness of PGx utility, complex interpretation of results, and time constraints. Through qualitative analysis, this study aimed to identify clinician preferences regarding the educational, technical, and workflow supports needed to effectively integrate PGx results into EHRs. Clinicians practicing in a large academic health system in Western Pennsylvania, including physicians, advanced practice nurses, physician assistants, and pharmacists, were invited to participate in this study. The research team developed a semi-structured interview guide using the Consolidated Framework for Implementation Research (CFIR) as a framework. Interviews were conducted using videoconferencing software, transcribed, and analyzed using inductive reasoning analysis to identify key barriers and proposed solutions. Sixteen interviews were conducted, which revealed seven themes: (1) contextualization of utility; (2) clinician confidence and comfort; (3) consultations; (4) resulting and alerting; (5) communication of pharmacogenomic results; (6) decelerators; and (7) education preferences. Participants emphasized the need for simplified workflows, specialty-specific training, embedded EHR tools, and patient-centered communication strategies. Clinician-preferred strategies, including intuitive CDS tools, modular education resources, and streamlined communication pathways, are critical to successful PGx implementation. These findings offer a practical blueprint for integrating PGx into clinical practice and inform scalable models for precision medicine adoption across health systems. Further research should explore nuanced themes to further accelerate PGx deployments.

Verified
Journal Article
Open access
PDF file
EDErika Nicole Dreikorn
Erika Nicole Dreikorn
CMCarolyn Attention Carolyn Maxwell
Carolyn Attention Carolyn Maxwell
KRKayla Rowe
Kayla Rowe
BBBrianna M. Brooks
Brianna M. Brooks
CMChristine Munro
Christine Munro
MMMylynda B. Massart
Mylynda B. Massart
Background: Pharmacogenetics (PGx), which examines how genetic variations influence drug metabolism and response, offers promise in hospice care where patients commonly experience polypharmacy, complex symptoms, and limited life expectancy. This study assessed the utility of PGx results in guiding medication adjustments to improve symptom management at the end of life. Methods: A retrospective chart review was conducted on ten patients enrolled in a Precision Hospice Program who had PGx results for six key metabolic genes. A PGx-trained pharmacist reviewed Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline-based recommendations, which were discussed during interdisciplinary hospice team meetings. Results: Patients had a mean age of 85.7 years and were prescribed an average of 17.9 medications. Among the 27 prescriptions reviewed, actionable gene–drug interactions were identified, primarily involving antidepressants and analgesics. Three patients underwent medication changes based on PGx guidance, including switching from citalopram to bupropion and adding morphine to tramadol therapy, which improved symptom control. Conclusion: While not yet routinely implemented in hospice settings, this pilot study suggests PGx-guided prescribing can support personalized medication decisions and enhance emotional and physical comfort in end-of-life care when test results are available.

24 June 2026 in Frontiers in Medicine
Verified
Journal Article
Open access
EDErika Nicole Dreikorn
Erika Nicole Dreikorn
LGLucy Galea
Lucy Galea
NBNatasha Robin Berman
Natasha Robin Berman
CMChristine Munro
Christine Munro
BPBrianne Phillips
Brianne Phillips
MMMylynda B. Massart
Mylynda B. Massart
Introduction: Precision medicine has traditionally been delivered in specialty settings, limiting access for many patients. Primary care offers a potential entry point for broader delivery of genomic services within primary care, given its central role in longitudinal and preventive care. In this study, we characterize five years of sustained real-world delivery of both diagnostic and preventive genomic services within a family-medicine-embedded multidisciplinary clinic, examining patient population, referral patterns, clinical workflow, and genomic testing yield. Methods: We conducted a retrospective chart review of all new patients evaluated in the PCPM clinic at UPMC between November 6, 2019, and April 17, 2024 ( n = 1,602). Patients were seen via in-person and telemedicine visits for comprehensive family history assessment, genetic counseling, and clinician evaluation. Data collected included demographics, referral sources and indications, test types, and genetic testing outcomes. Summary statistics were reported using frequencies and proportions. Results: Genetic testing was ordered for 1,174 patients (73%), with 1,360 total tests ordered and an 83.4% completion rate. Panel-based testing accounted for 71% of all tests. Most tests (86%) were ordered for primary referral concerns, while 14% were prompted by incidental indications identified during intake. Clinic growth supported increased access, expanded staffing, and the development of a streamlined two-visit care model. Conclusion: These findings demonstrate that the sustained delivery of diagnostic and preventive genomics within a family medicine embedded multidisciplinary clinic model is feasible, enabling broad genomic evaluation, efficient testing workflows, and clinically meaningful diagnoses across diverse indications, offering a replicable template for health systems seeking to close the genomics access gap.

17 July 2026
Verified
Book Chapter
Closed access
PDF file
MMMylynda Beryl Massart
Mylynda Beryl Massart
LGLucy Galea
Lucy Galea
CMChris Munro
Chris Munro
EDErika Nicole Dreikorn
Erika Nicole Dreikorn

12 July 2026
Verified
Book Chapter
Closed access
PDF file
MMMylynda Beryl Massart
Mylynda Beryl Massart
LBLucas A. Berenbrok
Lucas A. Berenbrok
EDErika Nicole Dreikorn
Erika Nicole Dreikorn
NBNatasha Robin Berman
Natasha Robin Berman